Independent Financial Group’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$400K Buy
6,190
+194
+3% +$10.6K 0.01% 1083
2026
Q1
$314K Buy
5,996
+110
+2% +$5.59K 0.01% 1136
2025
Q4
$301K Buy
5,886
+396
+7% +$18.3K 0.01% 1147
2025
Q3
$213K Buy
+5,490
New +$189K 0.01% 1257

Other funds holding SBIO

Independent Financial Group's SBIO Position: Q2 2026 in Review

Independent Financial Group increased its ALPS Medical Breakthroughs ETF (SBIO) stake by 3.2% in Q2 2026, buying an estimated $10.6K and bringing the position to 6,190 shares worth $400K. The position accounts for 0.01% of the portfolio, ranked #1083.

Independent Financial Group first reported a position in SBIO in Q3 2025 and has held it in 4 quarters since. 65 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Independent Financial Group held 6,190 shares of ALPS Medical Breakthroughs ETF worth $400K as of Q2 2026.
  • Independent Financial Group bought 194 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $10.6K.
  • ALPS Medical Breakthroughs ETF made up 0.01% of Independent Financial Group's portfolio in Q2 2026, its #1083 holding.
  • Independent Financial Group first reported a position in ALPS Medical Breakthroughs ETF in Q3 2025 and has held it in 4 quarters since.
  • 65 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Independent Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.